Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 117

1.

Clinicopathologic features and treatment outcome of primary breast diffuse large B-cell lymphoma.

Niitsu N, Okamoto M, Nakamine H, Hirano M.

Leuk Res. 2008 Dec;32(12):1837-41. doi: 10.1016/j.leukres.2008.04.005. Epub 2008 May 19.

PMID:
18490056
2.

Addition of rituximab to standard chemotherapy improves the survival of both the germinal center B-cell-like and non-germinal center B-cell-like subtypes of diffuse large B-cell lymphoma.

Fu K, Weisenburger DD, Choi WW, Perry KD, Smith LM, Shi X, Hans CP, Greiner TC, Bierman PJ, Bociek RG, Armitage JO, Chan WC, Vose JM.

J Clin Oncol. 2008 Oct 1;26(28):4587-94. doi: 10.1200/JCO.2007.15.9277. Epub 2008 Jul 28.

PMID:
18662967
3.

De novo CD5+ diffuse large B-cell lymphoma: results of a detailed clinicopathological review in 120 patients.

Yamaguchi M, Nakamura N, Suzuki R, Kagami Y, Okamoto M, Ichinohasama R, Yoshino T, Suzumiya J, Murase T, Miura I, Ohshima K, Nishikori M, Tamaru J, Taniwaki M, Hirano M, Morishima Y, Ueda R, Shiku H, Nakamura S.

Haematologica. 2008 Aug;93(8):1195-202. doi: 10.3324/haematol.12810. Epub 2008 Jun 12.

4.

Primary cutaneous diffuse large B-cell lymphoma, leg type: clinicopathologic features and prognostic analysis in 60 cases.

Grange F, Beylot-Barry M, Courville P, Maubec E, Bagot M, Vergier B, Souteyrand P, Machet L, Dalac S, Esteve E, Templier I, Delaporte E, Avril MF, Robert C, Dalle S, Laroche L, Delaunay M, Joly P, Wechsler J, Petrella T.

Arch Dermatol. 2007 Sep;143(9):1144-50.

PMID:
17875875
5.

SIRT1 expression is associated with poor prognosis of diffuse large B-cell lymphoma.

Jang KY, Hwang SH, Kwon KS, Kim KR, Choi HN, Lee NR, Kwak JY, Park BH, Park HS, Chung MJ, Kang MJ, Lee DG, Kim HS, Shim H, Moon WS.

Am J Surg Pathol. 2008 Oct;32(10):1523-31. doi: 10.1097/PAS.0b013e31816b6478.

PMID:
18724249
6.

Clinicopathologic correlations of stage IE/IIE primary thyroid diffuse large B-cell lymphoma.

Niitsu N, Okamoto M, Nakamura N, Nakamine H, Bessho M, Hirano M.

Ann Oncol. 2007 Jul;18(7):1203-8. Epub 2007 Apr 11.

PMID:
17429099
7.

Intravascular large B-cell lymphoma (IVLBCL): a clinicopathologic study of 96 cases with special reference to the immunophenotypic heterogeneity of CD5.

Murase T, Yamaguchi M, Suzuki R, Okamoto M, Sato Y, Tamaru J, Kojima M, Miura I, Mori N, Yoshino T, Nakamura S.

Blood. 2007 Jan 15;109(2):478-85. Epub 2006 Sep 19.

8.

Clinicopathologic features and treatment outcome of non-Hodgkin lymphoma of the breast--a review of 42 primary and secondary cases in Taiwanese patients.

Lin YC, Tsai CH, Wu JS, Huang CS, Kuo SH, Lin CW, Cheng AL.

Leuk Lymphoma. 2009 Jun;50(6):918-24. doi: 10.1080/10428190902777475.

PMID:
19373599
9.

Primary breast non-Hodgkin's lymphoma: a large single center study of initial characteristics, natural history, and prognostic factors.

Validire P, Capovilla M, Asselain B, Kirova Y, Goudefroye R, Plancher C, Fourquet A, Zanni M, Gaulard P, Vincent-Salomon A, Decaudin D.

Am J Hematol. 2009 Mar;84(3):133-9. doi: 10.1002/ajh.21353.

10.

Germinal center B (GCB) and non-GCB cell-like diffuse large B cell lymphomas have similar outcomes following autologous haematopoietic stem cell transplantation.

Costa LJ, Feldman AL, Micallef IN, Inwards DJ, Johnston PB, Porrata LF, Ansell SM.

Br J Haematol. 2008 Jul;142(3):404-12. doi: 10.1111/j.1365-2141.2008.07207.x. Epub 2008 May 15.

PMID:
18492096
11.

Perforation predicts poor prognosis in patients with primary intestinal diffuse large B-cell lymphoma.

Chuang SS, Ye H, Yang SF, Huang WT, Chen HK, Hsieh PP, Hwang WS, Chang KY, Lu CL, Du MQ.

Histopathology. 2008 Oct;53(4):432-40. doi: 10.1111/j.1365-2559.2008.03140.x.

PMID:
18983608
12.

Serum soluble interleukin-2 receptor level and immunophenotype are prognostic factors for patients with diffuse large B-cell lymphoma.

Morito T, Fujihara M, Asaoku H, Tari A, Sato Y, Ichimura K, Tanaka T, Takata K, Tamura M, Yoshino T.

Cancer Sci. 2009 Jul;100(7):1255-60. doi: 10.1111/j.1349-7006.2009.01167.x. Epub 2009 Apr 22.

13.

Clinicopathologic correlations of diffuse large B-cell lymphoma in rheumatoid arthritis patients treated with methotrexate.

Niitsu N, Okamoto M, Nakamine H, Hirano M.

Cancer Sci. 2010 May;101(5):1309-13. doi: 10.1111/j.1349-7006.2010.01517.x. Epub 2010 Jan 28.

14.

Diffuse large B-cell lymphoma in the young in Japan: a study by the Osaka Lymphoma Study Group.

Yamauchi A, Fujita S, Ikeda J, Nakamichi I, Fukuhara S, Hino M, Kanakura Y, Ogawa H, Sugiyama H, Kanamaru A, Aozasa K.

Am J Hematol. 2007 Oct;82(10):893-7.

15.

Clinicopathologic significance of immunophenotypic profiles related to germinal center and activation B-cell differentiation in diffuse large B-cell lymphoma from Chinese patients.

Liu YH, Xu FP, Zhuang HG, Lai KC, Xie D, Luo DL, Li L, Luo XL, Xu J, Zhang MH, Zhang F, Li HM.

Hum Pathol. 2008 Jun;39(6):875-84. doi: 10.1016/j.humpath.2007.10.013. Epub 2008 Apr 28.

PMID:
18440593
16.

Molecular and immunological dissection of diffuse large B cell lymphoma: CD5+, and CD5- with CD10+ groups may constitute clinically relevant subtypes.

Harada S, Suzuki R, Uehira K, Yatabe Y, Kagami Y, Ogura M, Suzuki H, Oyama A, Kodera Y, Ueda R, Morishima Y, Nakamura S, Seto M.

Leukemia. 1999 Sep;13(9):1441-7.

PMID:
10482997
17.

Primary lymphoma of bone: extranodal lymphoma with favourable survival independent of germinal centre, post-germinal centre or indeterminate phenotype.

Heyning FH, Hogendoorn PC, Kramer MH, Holland CT, Dreef E, Jansen PM.

J Clin Pathol. 2009 Sep;62(9):820-4. doi: 10.1136/jcp.2008.063156.

PMID:
19734480
18.

MYC translocation and an increased copy number predict poor prognosis in adult diffuse large B-cell lymphoma (DLBCL), especially in germinal centre-like B cell (GCB) type.

Yoon SO, Jeon YK, Paik JH, Kim WY, Kim YA, Kim JE, Kim CW.

Histopathology. 2008 Aug;53(2):205-17. doi: 10.1111/j.1365-2559.2008.03076.x.

PMID:
18752503
19.

New prognostic relevant factors in primary cutaneous diffuse large B-cell lymphomas.

Hallermann C, Niermann C, Fischer RJ, Schulze HJ.

J Am Acad Dermatol. 2007 Apr;56(4):588-97. Epub 2007 Feb 7.

PMID:
17289214
20.

Patients with localized primary non-tonsillar oral diffuse large B-cell lymphoma exhibit favorable prognosis despite a non-germinal center B-cell-like phenotype.

Sato Y, Onishi N, Morito T, Takata K, Mizobuchi K, Nagatsuka H, Ichimura K, Tanaka T, Tamura M, Yoshino T.

Cancer Sci. 2009 Jan;100(1):42-6. doi: 10.1111/j.1349-7006.2008.00995.x. Epub 2008 Oct 23.

Supplemental Content

Support Center